This opportunity is currently closed.
Sign up for Content alerts to stay informed when this or related funding opportunities are posted.
Suicide Prevention Across the Life Span in Low- and Middle-Income Countries (R34 Clinical Trial Optional) (worldwide)
The Suicide Prevention Across the Life Span in Low- and Middle-Income Countries (R34 Clinical Trial Optional) funding from the National Institutes of Health (NIH) supports experimental and non-experimental research that evaluates multilevel preventive strategies to reduce suicide risk (suicide ideation and behavior, including acts of self-harm/suicide) and promote resilience across the life span in low-and middle-income countries (LMICs). Globally, there is a critical need to implement culturally adapted multilevel preventive approaches at the individual (selective prevention) and population level (universal prevention) for people across the lifespan in LMICs, focusing on multiple risks and protective factors. Applications are open to researchers at research institutions in the USA and worldwide. The grant provides 450,000 USD for up to 3 years.
Funding opportunity number: RFA-MH-23-260.
Letters of intent are due on: May 20, 2023.
Applications close on: June 20, 2023.
June 20, 2023